Contract Notice Detail

Summary Information

Summary Information
31,973.609996 Euro
 
ULS S. José 51031424 
AQUISIÇÃO DE DEXAMETASONA(FOSF) 5 MG/1 ML SOL INJ E DE DICLOFENAC 100 MG SUP 
Tendering Phase
ClosedForReplies
DEXAMETASONA(FOSF) 5 MG/1 ML SOL INJ 1 ML I.ARTIC IM I.SINOV IV (4MG DEXAMETAS.) e DICLOFENAC 100 MG SUP 
VortalGOV - Acquisition under a Framework Agreement (via Direct Award) 
Lot NameLot Base PriceExpected Duration
D39 - DEXAMETASONA [5MG/1ML; F/AMP]-192 (Days)
D80 - DICLOFENAC [100MG; SUP]-192 (Days)

Object of the Contract

Object of the Contract
Supplies Acquisition 
Rua José António Serrano 1150-199 Arroios Lisboa PORTUGAL  
33600000-6 - Pharmaceutical products
 
 
 

Scheduling

Scheduling
6/24/2024 3:46 PM (UTC +1 hour)
 
1/15/2024 11:59 AM (UTC 0 hours)
 
6/27/2024 4:30 PM (UTC +1 hour)
 

Financial Settings

Financial Settings
No 

Contract Documents

Contract Documents
Document NameDescriptionDoc Classification
Convite.pdfConvite.pdfDownload

Object of contract

No 
No 

Legal, economic, financial and technical information

No 

Questionnaire

Questionnaire
1
Lot Title
D39 - DEXAMETASONA [5MG/1ML; F/AMP]
Base Price
31 970,000000

1.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
10058906 DEXAMETASONA [5MG/1ML; F/AMP] 23 000,000000 NXTWY.UMT.17648
Buyer Comment: 513077332 | BDR Pharma, Lda. | CPA:2024780/896/0168 | NºAIM:3974581;
TOTAL (The amounts shown do not include VAT)
2
Lot Title
D80 - DICLOFENAC [100MG; SUP]
Base Price
3,609996

2.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
10007057 DICLOFENAC [100MG; SUP] 12,000000 NXTWY.UMT.17648
Buyer Comment: 500063524 | Novartis Farma - Produtos Farmacêuticos, S.A. | CPA:2024780/128/0272 | NºAIM:9447037;
TOTAL (The amounts shown do not include VAT)

Evaluation

Evaluation
Vision

Avaliação

Definir modelo de avaliação
Modalidade de avaliação
Método de Avaliação
Divulgar critérios de avaliação

Critérios da Avaliação

1 - D39 - DEXAMETASONA [5MG/1ML; F/AMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

2 - D80 - DICLOFENAC [100MG; SUP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

Public Messages

Public Messages
TypeReferenceSubjectDate
No items found...